Royalty Pharma RPRX
NASDAQ RPRX
$63.99 +0.11 (+0.17%)
As of: Sep 4, 2026 · 3:59 PM EDT

Royalty Pharma (RPRX) Dividend Yield (2020 - 2026)

Analysis

Royalty Pharma (RPRX) Dividend Yield (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.11%
Mar 31, 2026 0.14%
Dec 31, 2025 0.18%
Sep 30, 2025 0.17%
Jun 30, 2025 0.18%
Mar 31, 2025 0.31%
Dec 31, 2024 0.21%
Sep 30, 2024 0.19%
Jun 30, 2024 0.20%
Mar 31, 2024 0.18%
Dec 31, 2023 0.15%
Sep 30, 2023 0.19%
Jun 30, 2023 0.17%
Mar 31, 2023 0.15%
Dec 31, 2022 0.14%
Sep 30, 2022 0.16%
Jun 30, 2022 0.15%
Mar 31, 2022 0.15%
Dec 31, 2021 -0.95%
Sep 30, 2021 0.57%